Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Reviewing Medtronic Activa Reimbursement For Bilateral Indication

This article was originally published in The Gray Sheet

Executive Summary

The Centers for Medicare & Medicaid Services has initiated a national coverage review of Medtronic's Activa for bilateral brain stimulation in Parkinson's disease patients, but the agency will not reimburse the indication until it is approved by FDA.

You may also be interested in...



MCAC Panel Recommends Coverage Decision Of Bilateral DBS For Parkinson’s

Medicare coverage conditions for bilateral deep-brain stimulation to treat Parkinson's disease should stipulate that procedures be performed by a "specialized team" of movement-disorder neurologists and neurosurgeons, Medicare Coverage Advisory Committee panel members concluded June 12

MCAC Panel Recommends Coverage Decision Of Bilateral DBS For Parkinson’s

Medicare coverage conditions for bilateral deep-brain stimulation to treat Parkinson's disease should stipulate that procedures be performed by a "specialized team" of movement-disorder neurologists and neurosurgeons, Medicare Coverage Advisory Committee panel members concluded June 12

Medtronic Activa Postmarket Study On Parkinson’s Will Begin By Summer

Medtronic's 230-patient, three-year post-approval study of its Activa Parkinson's disease neurostimulation therapy will begin enrollment by this summer

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel